Search
  • Kirk Hartley

A No Direct Cost Way to Support More Mesothelioma Research

Investing in more mesothelioma research should be a no brainer. Investments in research should be flowing from many, including especially Warren Buffet/Resolute/Berkshire, other insurers, reinsurers, defendant companies, futures representatives, asbestos trusts, and lawyers. But most are not investing in research. Happily, others are making the effort to increase mesothelioma research funding, as highlighted by a new request for action from Mary Hesdorffer at MARF. There’s no cost – just send an email or make a call to your representative in the House. MARF’s web site provides the link to obtain that information if you do not have it handy. I’ve pasted below the text from MARF – please take 5 minutes and support the cause. Or make a donation to some other cancer research group.

_____________________________________________

Dear supporter of mesothelioma research.

We need your help!

In March, Congresswoman Carolyn Maloney (D-NY) developed a formal letter requesting the U.S. House of Representatives Appropriations Committee Defense Subcommittee dedicate $40 million for the Peer-Reviewed Cancer Research Program (PRCRP) in the Fiscal Year 2015 Defense Appropriations bill. The $40 million represents a $15 million increase over the 2014 level for the PRCRP. Mesothelioma is one of the cancers eligible to compete for funding under this program.

Since then, the Senate Appropriations Committee passed a funding level of $50 million for the PRCRP, which would double the program’s 2014 level. Representative Maloney is now requesting that the House Appropriations Defense Subcommittee agree to the Senate level for the program in conference on the final version of the Fiscal 2015 Defense Appropriations bill. This is the bill that will go to the President to be signed into law.

If the Congress agrees to the $50 million for the PRCRP, it would represent a significant increase in funding for all applicable cancers, including Defense-funded mesothelioma research.

A “Dear Colleague” email went out last week, urging support. So far, the letter has been signed by Representatives Michael Fitzpatrick (R-PA), Eleanor Holmes Norton (D-DC), Charlie Rangel (D-NY), Sander Levin (D-MI), and Collin Peterson (D-MN). Additional support for this is critical!

Please take a moment to contact your House representative to request they sign on.

Look up your elected officials’ phone numbers.

Here is what you say:

Hi, my name is _________ and I am a constituent of Congressman/woman _________. I am calling to request for your boss to sign on to a Dear Colleague letter circulated by Congresswoman Maloney in support of $50 million in cancer research funding in the defense budget that has already been passed by the Senate committee.

Thank you!

0 views

About Kirk

Since becoming a lawyer in 1983, Kirk’s over 30 years of practice have focused on advising a wide range of corporations, associations, and individuals (as both plaintiffs and defendants) on both tort and commercial law issues centered around “mass torts.”

Read More...

Copyright © 2020, GlobalTort All Rights Reserved.